HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Government Will Conduct Abortion Pill Review Amid Studies Showing Possible Dangers A recent report shows that more than 1 in 10 women experience adverse side effects from chemical abortions.

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...

A new study has led to Health and Human Services Secretary Robert F. Kennedy, Jr. to order a “complete review” of the abortion pill, mifepristone, amid queries from Congress. Sen. Josh Hawley (R-MO) ...

US HHS Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions.

Food and Drug Administration (FDA) head Marty Makary vowed to review the abortion drug mifepristone after previously saying he had no plans to take action on the drug.

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. Food and Drug Administration Commissioner ...